Veeva Systems Q2 Revenue Rises 17% Surpassing Estimates

Veeva Systems, a leader in cloud software for the life sciences industry, reported strong fiscal second quarter 2026 results with revenue of $789.1 million, a 17% increase year over year, surpassing analyst estimates. Non-GAAP earnings per share reached $1.99, beating expectations and reflecting robust customer adoption across commercial and R&D product lines. The company raised its full-year revenue guidance to approximately $3.14 billion, up from prior estimates, signaling confidence in continued growth driven by its integrated cloud platforms and AI initiatives. While operating margins have shown some long-term decline and insider selling has been noted, Veeva maintains strong profitability and a solid financial position with low leverage and high liquidity. Analysts generally rate Veeva as an outperform with an average price target near $301, indicating modest upside potential from current prices. Despite a slight deceleration in projected revenue growth, Veeva’s strategic focus on expanding its cloud offerings and maintaining compliance positions it well in the competitive life sciences technology market.